Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Bonesupport Holding
OM:BONEX Community
1
Narratives
written by author
0
Comments
on narratives written by author
22
Fair Values set
on narratives written by author
Create a narrative
Bonesupport Holding
Popular
Undervalued
Overvalued
Bonesupport Holding
AN
Analyst Price Target
Consensus Narrative from 3 Analysts
CERAMENT G's US Launch And CERAMENT V's FDA Submission Will Expand Global Presence
Key Takeaways CERAMENT G's rapid U.S. penetration addresses a significant market need, likely causing notable revenue growth due to its strong clinical backing. Expanding into new markets and launching a sales booster program aim to enhance market reach and revenue growth, leveraging successful strategies and clinical credibility.
View narrative
SEK 445.33
FV
25.5% undervalued
intrinsic discount
44.33%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
BONEX
Bonesupport Holding
Your Fair Value
SEK
Current Price
SEK 331.80
66.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-176m
3b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 3.4b
Earnings SEK 505.9m
Advanced
Set as Fair Value